National Cancer Society Malaysia (NCSM) has partnered with Gene Solutions to boost multi-cancer early detection (MCED) in Malaysia.
Formalised through a memorandum of understanding (MOU), this collaboration is focused on enhancing awareness and improving access to MCED testing in the country.
Go deeper with GlobalData
The partnership was signed at the National Cancer Congress Malaysia 2024, marking a significant step towards transforming cancer detection and elevating early diagnosis rates nationwide.
By integrating NCSM’s network with Gene Solutions’ MCED technology, the initiative aims to raise awareness about the critical role of early cancer detection and extend testing accessibility to a wider demographic.
The collaboration will concentrate on several pivotal areas, including awareness campaigns to inform the public about MCED testing benefits and availability, and community outreach programmes to disseminate information and resources.
Other key focus areas of the partnership are strategies to make MCED tests more accessible, and joint research projects to evaluate the effectiveness of the testing in Malaysia.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNCSM managing director Dr Murallitharan Munisamy said: “Our partnership with Gene Solutions is a testament to our commitment to reducing the cancer burden in Malaysia. Early detection is vital in the fight against cancer, and through this collaboration, we aim to empower more Malaysians with the knowledge and tools needed for early diagnosis.”
The alliance between NCSM and Gene Solutions underscores a mutual dedication to improving Malaysian healthcare through preventive measures.
Leveraging the strengths of both organisations, the partnership hopes to establish new precedents in cancer awareness and early detection efforts.
Gene Solutions Malaysia business lead Chiun Khee Lim said: “Gene Solutions is dedicated to advancing cancer diagnostics, and our collaboration with National Cancer Society Malaysia aligns perfectly with our mission to make early cancer detection more accessible.
“Together, we can make a significant impact on public health by identifying cancers at an earlier, more treatable stage.”
